Aquestive Therapeutics Statistics
NASDAQ: AQSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.76+0.14 (+3.03%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 4.77 +0.21%
Aquestive Therapeutics by the numbers
Aquestive Therapeutics has a market capitalization of $597.4 million based on 125.51M shares outstanding. With trailing EPS of $-0.66, Aquestive Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.3% above its 50-day average and 10.1% above its 200-day average.
Average daily trading volume is 2.66M shares, or about $12.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AQST valuation vs. peer median
| Metric | AQST | Peer median | Difference |
|---|---|---|---|
| Market cap | $597.44M | $565.87M | +6% |
| Avg. volume | 2.66M | 1.16M | +129% |
Peer median across 8 companies: PHAT, CRMD, STTK, SLN, MNPR, EVO, ACRS, CTMX.
Valuation
- Market cap
- $597.44M
- EPS (TTM)
- $-0.66
- Shares outstanding
- 125.51M
Price and trading
- Previous close
- 4.62
- Open
- 4.60
- Day range
- 4.55 – 4.85
- 52-week range
- 2.93 – 7.55
- 52-week change
- -22.61%
- Beta
- —
- Volume
- 2.32M
- Average volume
- 2.66M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 597.44M
- Forward Pe
- -8.35
- Eps
- -0.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.55
- Week52 Low
- 2.93
- Avg Volume
- 2.66M
- Shares Outstanding
- 125.51M
- Ma50
- 4.61
- Ma200
- 4.32
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -36.95%
- Pct From52w Low
- 62.46%